Sreenivasa R. Oruganti, PhD

Sreenivasa joined GeoVax in 2020 with twenty years of research experience in molecular cell biology and immunology. Under the mentorship of Dr. Thomas Grundstrom at Umea University (Sweden), he completed a Ph.D. in Molecular Biology on the regulation of NF-kB transcription factor by calcium signaling in T cells. In 2011, he pursued postdoctoral training in the laboratory of Dr. Judy Cannon at the University of New Mexico, where he acquired knowledge of T cell immunology through research about T cell migration, both in cancer and infection models. He is a key member of the research and development team at GeoVax and assists in developing and accessing vaccine efficacy and immunogenicity.